Literature DB >> 7634848

Pseudotumor cerebri after treatment with tetracycline and isotretinoin for acne.

A G Lee1.   

Abstract

Tetracyclines and isotretinoin are widely used treatments for patients with acne. Although generally safe, the use of these agents has been associated with pseudotumor cerebri and combination therapy with these agents may increase the risk for pseudotumor cerebri. A 14-year-old boy presented with headaches and bilateral visual loss secondary to papilledema. He had been treated with tetracycline and isotretinoin for acne for three weeks prior to presentation and was subsequently diagnosed as having pseudotumor cerebri. He required long-term medical therapy and eventually underwent bilateral optic nerve sheath decompression. The literature regarding pseudotumor cerebri in association with tetracyclines and isotretinoin treatment for acne is reviewed. Dermatologists should be aware of the risk of pseudotumor cerebri in patients receiving tetracycline or isotretinoin treatment for acne and should be particularly cautious about using both agents simultaneously.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7634848

Source DB:  PubMed          Journal:  Cutis        ISSN: 0011-4162


  9 in total

1.  The use of isotretinoin in acne.

Authors:  Alison Layton
Journal:  Dermatoendocrinol       Date:  2009-05

Review 2.  Ocular adverse effects associated with systemic medications : recognition and management.

Authors:  Ricardo M Santaella; Frederick W Fraunfelder
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 3.  Retinoic acid and affective disorders: the evidence for an association.

Authors:  J Douglas Bremner; Kirsty D Shearer; Peter J McCaffery
Journal:  J Clin Psychiatry       Date:  2011-08-23       Impact factor: 4.384

4.  Structural and Functional Assessment in Patients Treated with Systemic Isotretinoin Using Optical Coherence Tomography and Frequency-Doubling Technology Perimetry.

Authors:  Berker Bakbak; Sansal Gedik; Bengu Ekinci Koktekir; Huseyin Guzel; Hilmi Cevdet Altınyazar
Journal:  Neuroophthalmology       Date:  2013-05-31

5.  Combination of low-dose isotretinoin and pulsed oral azithromycin in the management of moderate to severe acne: a preliminary open-label, prospective, non-comparative, single-centre study.

Authors:  Dipankar De; Amrinder J Kanwar
Journal:  Clin Drug Investig       Date:  2011       Impact factor: 2.859

Review 6.  Neuromuscular adverse effects associated with systemic retinoid dermatotherapy: monitoring and treatment algorithm for clinicians.

Authors:  Elisabeth Chroni; Alexandra Monastirli; Dionysios Tsambaos
Journal:  Drug Saf       Date:  2010-01-01       Impact factor: 5.606

7.  Comparison of the Efficacy of Azithromycin Versus Doxycycline in Acne Vulgaris: A Meta-Analysis of Randomized Controlled Trials.

Authors:  Jung Eun Kim; A Young Park; Sung Yul Lee; Young Lip Park; Kyu Uang Whang; Hyun-Jung Kim
Journal:  Ann Dermatol       Date:  2018-06-28       Impact factor: 1.444

Review 8.  A Review of Systemic Minocycline Side Effects and Topical Minocycline as a Safer Alternative for Treating Acne and Rosacea.

Authors:  Ana M Martins; Joana M Marto; Jodi L Johnson; Emmy M Graber
Journal:  Antibiotics (Basel)       Date:  2021-06-22

9.  Intracranial hypertension associated with topical tretinoin use.

Authors:  Suzie Gasparian; Xianzhang Geng; Eman Hawy
Journal:  Am J Ophthalmol Case Rep       Date:  2021-06-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.